A drug recently approved to prevent migraine may start working right away, according to a new study. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor ...
Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...
Atogepant, a recently approved drug for migraine, may start working as soon as day 1 of treatment, according to a recent study published in Neurology. | Neuroscience ...
“With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks or even months for it to be most effective,” said study author Richard ...